Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jaktinib Extension in Alopecia Areata
NCT05255237Phase 3Completed
- Sponsor
- Zelgen
- Start
- Mar 2022
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of jaktinib in alopecia areata, sponsored by Zelgen. Started Mar 2022; status: completed.
02
Drugs
jaktinib
03
Conditions
alopecia areata
Beyond the preview
Go deeper on NCT05255237.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05255237.